Sponsor Pipeline

Lantu Biopharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07265232 Real World Clinical Effectiveness & Safety of Vesemnogene Lantuparvovec for Spinal… Spinal Muscular Atrophy (SMA) Recruiting
Phase 1/2
NCT06288230 An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal… Spinal Muscular Atrophy Active, Not Recruiting
NCT06308159 An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion… Beta-Thalassemia Active, Not Recruiting
Disease Areas
Spinal Muscular Atrophy (2) Thalassemia (1)
Get alerts when Lantu Biopharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free